Bulk anti-Human HLA-DP antibody (B7/21)
- Sizes: 5mg, 25mg, 50mg, 100mg,
- Category: ichorbio, Ultra Low Endotoxin, anti-human
- Target: HLA-DP
- Clone: B7/21
- Host: Mouse
-
Datasheet Tech Support
PRODUCT DETAILS
SPECIFICATIONS |
|
---|---|
PRODUCT NAME |
Bulk anti-Human HLA-DP antibody (B7/21) |
SPECIES REACTIVITY |
Human |
HOST |
Mouse |
SPECIFICITY |
Anti-HLA-DP In Vivo Antibody - Low Endotoxin (B7/21) recognizes a (Mr 26-34 kDa) class II major histocompatibility complex (MHC) antigen. The antibody recognizes a monomorphic determinant present on cells expressing DP1, DP2, DP3, DP4 and DP5. |
PURIFICATION METHOD |
|
ANTIGEN DISTRIBUTION |
The HLA-DP antigen is present on approximately 10% of normal peripheral blood lymphocytes but not on resting peripheral T-lymphocytes. HLA-DP is present in low density on peripheral blood monocytes and mitogen-stimulated T-lymphoblasts. Anti-HLA-DP reacts with most B-cell lines. |
IMMUNOGEN |
Unknown |
CONCENTRATION |
|
FORMULATION |
No carrier proteins or preservatives added in 0.01 M phosphate buffered saline (PBS) pH 7.2 - 7.4. |
PURITY |
>98% by SDS-PAGE and HPLC |
ENDOTOXIN |
≤ 0.75 EU/mg as determined by the LAL method |
AGGRIGATION |
Aggregation level ≤ 1% |
STORAGE CONDITION |
anti-HLA-DP In Vivo Antibody - Low Endotoxin (B7/21) is stable for at least six (6) weeks when stored at 2-8°C. For long-term storage, aliquot in working volumes without diluting and store at – 20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles. |
TARGET |
|
---|---|
TARGET |
HLA-DP |
CLONE |
B7/21 |
SYNONYMS |
|
BACKGROUND |
|
UNIPROT |
|
PATHOGEN TEST |
We use the IMPACT test generated by IDEXX Laboratories to guarantee our Ultra Low Endotoxin antibodies are pathogen free. Our mouse antibodies are tested for: |
APPLICATIONS |
Western Blot, Immunocytochemistry, Flow Cytometry |
APPLICATION NOTES |
Each investigator should determine their own optimal working dilution for specific applications. |
USAGE |
Products are for research use only. Not for use in diagnostic or therapeutic procedures. |